The consortium said the offer is aimed at delisting Recordati from Euronext Milan and supporting the drugmaker’s expansion in rare diseases.
Source link
The consortium said the offer is aimed at delisting Recordati from Euronext Milan and supporting the drugmaker’s expansion in rare diseases.
Source link